or Try an Advanced Search...

    Biomarin Pharmaceutical Stocks List

    Symbol Grade Name % Change
    BMRN A BioMarin Pharmaceutical Inc. 2.87
    CPRX B Catalyst Pharmaceutical Partners, Inc. -2.45
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Virotherapy Achondroplasia Autoimmune Disease Biopharmaceutical Cancer Disorders Drug Discovery Enzyme Replacement Therapy Epilepsy Genetic Diseases Genzyme Glycogen Storage Disorder Health Sciences Iduronidase Inborn Errors Of Metabolism Intellectual Disability Lysosomal Storage Disorder Medication

    Related ETFs - A few ETFs which own one or more of the above listed Biomarin Pharmaceutical stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 8.65
    GNOM F Global X Genomics & Biotechnology ETF 4.02
    FBT D First Trust Amex Biotech Index Fund 3.41
    GDOC C Goldman Sachs Future Health Care Equity ETF 3.32
    IBRN D iShares Neuroscience and Healthcare ETF 3.18
    View all Biomarin Pharmaceutical ETFs...
    Compare ETFs
    Compare FBT to IBRN Compare GNOM to GDOC Compare PBE to GDOC

        Biomarin Pharmaceutical Stocks Recent News

        Date Stock Title
        Apr 22 BMRN BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says
        Apr 22 BMRN Gear Up for BioMarin (BMRN) Q1 Earnings: Wall Street Estimates for Key Metrics
        Apr 22 CPRX Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
        Apr 18 CPRX Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who own 65% of the company
        Apr 18 BMRN Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
        Apr 17 BMRN BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Virotherapy Achondroplasia Autoimmune Disease Biopharmaceutical Cancer Disorders Drug Discovery Enzyme Replacement Therapy Epilepsy Genetic Diseases Genzyme Glycogen Storage Disorder Health Sciences Iduronidase Inborn Errors Of Metabolism Intellectual Disability Lysosomal Storage Disorder Medication
        Biomarin Pharmaceutical

        Biomarin Pharmaceutical is a biopharmaceutical company that develops and commercializes innovative therapies for patients with serious and life-threatening rare diseases. The company focuses on developing treatments for genetic disorders, cancer, and other rare diseases. Biomarin has a portfolio of approved therapies and a robust pipeline of product candidates in clinical and preclinical development.

        Browse All Tags